Yang Feng, Zhang Lulu, Wakabayashi Hironao, Myers Jason, Jiang Yuanying, Cao Yongbing, Jimenez-Ortigosa Cristina, Perlin David S, Rustchenko Elena
Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New York, USA.
Center for New Drug Research, School of Pharmacy, Second Military Medical University, Shanghai, People's Republic of China.
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.00071-17. Print 2017 May.
Expanding echinocandin use to prevent or treat invasive fungal infections has led to an increase in the number of breakthrough infections due to resistant species. Although it is uncommon, echinocandin resistance is well documented for , which is among the most prevalent bloodstream organisms. A better understanding is needed to assess the cellular factors that promote tolerance and predispose infecting cells to clinical breakthrough. We previously showed that some mutants that were adapted to growth in the presence of toxic sorbose due to loss of one chromosome 5 (Ch5) also became more tolerant to caspofungin. We found here, following direct selection of mutants on caspofungin, that tolerance can be conferred by at least three mechanisms: (i) monosomy of Ch5, (ii) combined monosomy of the left arm and trisomy of the right arm of Ch5, and (iii) an aneuploidy-independent mechanism. Tolerant mutants possessed cell walls with elevated chitin and showed downregulation of genes involved in cell wall biosynthesis, namely, , located outside Ch5, and , located on Ch5, irrespective of Ch5 ploidy. Also irrespective of Ch5 ploidy, the and genes on Ch5, which are involved in the calcineurin signaling pathway, were expressed at the diploid level. Thus, multiple mechanisms can affect the relative expression of the aforementioned genes, controlling them in similar ways. Although breakthrough mutations in two specific regions of have previously been associated with caspofungin resistance, we found mechanisms of caspofungin tolerance that are independent of and thus represent an earlier event in resistance development.
扩大棘白菌素的使用以预防或治疗侵袭性真菌感染已导致由于耐药菌株引起的突破性感染数量增加。尽管这种情况并不常见,但棘白菌素耐药性在 (最常见的血流病原体之一)中已有充分记录。需要更好地了解促进耐受性并使感染细胞易发生临床突破的细胞因素。我们之前表明,一些由于丢失一条5号染色体(Ch5)而适应在有毒山梨糖存在下生长的突变体,对卡泊芬净也变得更具耐受性。我们在此发现,在卡泊芬净上直接筛选突变体后,耐受性可通过至少三种机制产生:(i)Ch5单体性,(ii)Ch5左臂单体性与右臂三体性的组合,以及(iii)一种非整倍体依赖性机制。耐受性突变体的细胞壁几丁质含量升高,并且参与细胞壁生物合成的基因,即位于Ch5之外的 和位于Ch5上的 ,无论Ch5倍性如何均表现出下调。同样无论Ch5倍性如何,参与钙调神经磷酸酶信号通路的Ch5上的 和 基因以二倍体水平表达。因此,多种机制可影响上述基因的相对表达,并以相似方式对其进行调控。尽管之前已发现 的两个特定区域中的突破性突变与卡泊芬净耐药性有关,但我们发现了与 无关的卡泊芬净耐受性机制,因此代表了耐药性发展中的早期事件。